Needham Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating
Morgan Stanley Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $655
Vertex Pharmaceuticals Analyst Ratings
Wells Fargo Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,125
Evercore Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $605
Barclays Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,200
Thermo Fisher Price Target Raised to $658.00/Share From $648.00 by TD Cowen
Redburn Atlantic Adjusts Price Target on Danaher to $280 From $260
Raymond James Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $660
Navigating 5 Analyst Ratings For Thermo Fisher Scientific
A Quick Look at Today's Ratings for Thermo Fisher Scientific(TMO.US), With a Forecast Between $600 to $664
Argus Research Initiates Danaher(DHR.US) With Buy Rating, Announces Target Price $300
Cantor Fitzgerald Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $885
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $655 From $650, Maintains Buy Rating
Thermo Fisher Price Target Raised to $632.00/Share From $620.00 by Baird
Thermo Fisher Scientific Analyst Ratings
Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $120
Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Edwards Lifesciences (EW)
Eli Lilly and Co Analyst Ratings
Wolfe Research Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,117